Competitive Environment
-
Number of Competitors: 200+
-
Leading Competitors: Aktana, Trinity Life Sciences, Eversana, Axtria, Syneos Health, IQVIA, ZS Associates
-
Other Notable Competitors: Open Health, Icon PLC, Inizio, Exeevo, Amplity Health, Viseven, Promoveo Health, MaBiCo, Indegene, etc.
-
Notable Acquisitions and Mergers: Acquisition of Tact.ai by Aktana; Eversana's acquisition of Healthware Group
Source: Frost & Sullivan Analysis
The pharmaceutical industry is undergoing a significant transformation towards patient-centric care delivery, requiring companies to adopt a robust, step-by-step approach to market commercialization. This involves a comprehensive understanding of market stakeholders and segments, enabling pharma organizations to create effective go-to-market strategies that meet the dynamic needs of healthcare providers and patients. However, as the market becomes more complex, innovative solutions are essential for ensuring effective market presence. Consequently, marketing and sales strategies must navigate a multitude of stakeholders, regulatory bodies, and technology vendors to maintain a competitive edge.
Download Now
Strategic Imperatives for Success
Transformative Megatrends
HEOR Growth
Over the next 3 to 5 years, Health Economics and Outcomes Research (HEOR) services will become increasingly vital, supporting pharmaceutical companies in understanding health outcomes and their impact on drug launches.
Innovative Business Models
Technology Investment
Firms are seeking partnerships with tech vendors for predictive analytics and cloud infrastructure while building in-house capabilities for field optimization and omnichannel marketing.
Disruptive Technologies
Digital Transformation
In the upcoming years, tech and artificial intelligence (AI) vendors will drive large-scale digitization of the commercial value chain, enhancing data management and optimizing access for healthcare professionals (HCPs).
Investment Trends
-
Technology Partnerships: Companies are increasingly collaborating with Software-as-a-service (SaaS) vendors and cloud service providers to harness the power of AI/machine language (ML) and predictive analytics.
-
Strategic Industry Collaboration: Pure-play vendors are partnering with specialized service providers to build enhanced HEOR, customer relationship management (CRM), and go-to-market strategies.
-
Mergers and Acquisitions: Many pure-play vendors are expanding their portfolios through acquisitions focused on market access and AI implementation.
-
In-House Expansions: Companies are prioritizing in-house capabilities to meet growing commercialization demands, particularly in omnichannel marketing and outcome research.
Discover how your organization can thrive in this competitive landscape. Access Frost & Sullivan's latest analysis for in-depth insights and strategic recommendations tailored for the pharma industry.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium as a token of our appreciation, which can be used towards the purchase of our products or services.
